Table of Contents Author Guidelines Submit a Manuscript
Canadian Journal of Gastroenterology
Volume 26 (2012), Issue 3, Pages 125-129
http://dx.doi.org/10.1155/2012/890698
Original Article

Clinical Significance of Autoantibodies to P53 Protein in Patients with Autoimmune Liver Diseases

Takashi Himoto,1 Hirohito Yoneyama,2 Kazutaka Kurokohchi,2 Michio Inukai,1 Hisashi Masugata,1 Fuminori Goda,1 Reiji Haba,3 Seishiro Watanabe,4 Shoichi Senda,1 and Tsutomu Masaki2

1Department of Integrated Medicine, Kagawa University School of Medicine, Japan
2Department of Gastroenterology and Neurology, Kagawa University School of Medicine, Japan
3Department of Diagnosis Pathology, Kagawa University School of Medicine, Japan
4Department of Internal Medicine, Kagawa Prefectural Central Hospital, Kagawa, Japan

Received 12 June 2011; Accepted 2 July 2011

Copyright © 2012 Hindawi Publishing Corporation. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

How to Cite this Article

Takashi Himoto, Hirohito Yoneyama, Kazutaka Kurokohchi, et al., “Clinical Significance of Autoantibodies to P53 Protein in Patients with Autoimmune Liver Diseases,” Canadian Journal of Gastroenterology, vol. 26, no. 3, pp. 125-129, 2012. doi:10.1155/2012/890698